Company Valuation: PharmaEngine, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027
Market Cap 1 10,207 17,961 15,158 12,974 10,115 7,543 -
Change - 75.96% -15.6% -14.41% -22.04% -25.43% -
Enterprise Value (EV) 8,057 17,961 14,283 12,974 10,115 7,543 7,543
Change - 122.93% -20.48% -9.16% -22.04% -25.43% 0%
P/E 24.7x 56.3x 55.2x 7.42x 26.2x 14.1x 14.7x
PBR 2.67x 4.64x 3.92x 2.4x 2.05x 1.5x 1.47x
PEG - -2.3x -4x 0x -0.3x 0.4x -3.42x
Capitalization / Revenue 15.6x 27.4x 19.7x 5.14x 11.1x 7.46x 7.38x
EV / Revenue 0x 0x 0x 0x 0x 7.46x 7.38x
EV / EBITDA - - - - - - -
EV / EBIT 0x 0x 0x 0x 0x 14.5x 14x
EV / FCF - - - - - - -
FCF Yield - - - - - - -
Dividend per Share 2 2.7 2 1.5 6 - - -
Rate of return 3.72% 1.6% 1.42% 6.64% - - -
EPS 2 2.94 2.22 1.91 12.17 2.69 3.72 3.56
Distribution rate 91.8% 90.1% 78.5% 49.3% - - -
Net sales 1 654.8 654.4 767.7 2,523 911.4 1,011 1,022
EBITDA 373 - 286.2 2,062 - - -
EBIT 1 362.7 282.7 277.2 2,053 425.5 521 539
Net income 1 426 318.8 274.6 1,751 387.6 534 511
Net Debt -2,151 - -875.6 - - - -
Reference price 2 72.60 125.00 105.50 90.30 70.40 52.50 52.50
Nbr of stocks (in thousands) 140,596 143,687 143,679 143,678 143,678 143,678 -
Announcement Date 3/8/22 A 3/17/23 A 2/29/24 A 2/27/25 A 3/11/26 A - -
1TWD in Million2TWD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
13.84x - - - 225M
17.32x6.64x12.72x1.72% 66.37B
31.83x8.5x28.08x0.07% 58.86B
38.41x6.84x20.46x0.85% 55.22B
44.35x6.2x29.52x-.--% 47.21B
33.62x3.22x13.9x-.--% 42.45B
35.98x8.9x23.21x0.36% 36.44B
-19.28x55.7x-21.11x-.--% 35.19B
41.59x8.02x26.91x-.--% 32.66B
-74.36x14.09x-75.73x-.--% 26.73B
Average 16.33x 13.12x 6.44x 0.33% 40B
Weighted average by Cap. 21.60x 11.64x 11.39x 0.44%

Y-o-Y evolution of P/E

Valuation ratios - P/E - PharmaEngine, Inc.

Historical PBR trend

Valuation ratios - PBR - PharmaEngine, Inc.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - PharmaEngine, Inc.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - PharmaEngine, Inc.

  1. Stock Market
  2. Stocks
  3. 4162 Stock
  4. Valuation PharmaEngine, Inc.